| . | ≤ −3 SD . | > −3 to ≤ −2,5 SD . | > −2,5 to −2 SD . |
|---|---|---|---|
| Number of patients | 22 | 23 | 29 |
| Girls/boys | 9/13 | 13/10 | 10/19 |
| Median age in years (range) | 9.7 (4.1–16.4) | 11.1 (4.2–14.3) | 10.5 (5.7–16.6) |
| GHD, % | 13.6% | 43.5% | 44.8% |
| SGA, % | 45.5% | 26.1% | 27.6% |
| Bone dysplasia, % | 31.8% | 17.4% | 24.1% |
| ISS, % | 9.1% | 13.0% | 3.5% |
| . | ≤ −3 SD . | > −3 to ≤ −2,5 SD . | > −2,5 to −2 SD . |
|---|---|---|---|
| Number of patients | 22 | 23 | 29 |
| Girls/boys | 9/13 | 13/10 | 10/19 |
| Median age in years (range) | 9.7 (4.1–16.4) | 11.1 (4.2–14.3) | 10.5 (5.7–16.6) |
| GHD, % | 13.6% | 43.5% | 44.8% |
| SGA, % | 45.5% | 26.1% | 27.6% |
| Bone dysplasia, % | 31.8% | 17.4% | 24.1% |
| ISS, % | 9.1% | 13.0% | 3.5% |
Abbreviations: GHD, GH deficiency; ISS, idiopathic short stature.
| . | ≤ −3 SD . | > −3 to ≤ −2,5 SD . | > −2,5 to −2 SD . |
|---|---|---|---|
| Number of patients | 22 | 23 | 29 |
| Girls/boys | 9/13 | 13/10 | 10/19 |
| Median age in years (range) | 9.7 (4.1–16.4) | 11.1 (4.2–14.3) | 10.5 (5.7–16.6) |
| GHD, % | 13.6% | 43.5% | 44.8% |
| SGA, % | 45.5% | 26.1% | 27.6% |
| Bone dysplasia, % | 31.8% | 17.4% | 24.1% |
| ISS, % | 9.1% | 13.0% | 3.5% |
| . | ≤ −3 SD . | > −3 to ≤ −2,5 SD . | > −2,5 to −2 SD . |
|---|---|---|---|
| Number of patients | 22 | 23 | 29 |
| Girls/boys | 9/13 | 13/10 | 10/19 |
| Median age in years (range) | 9.7 (4.1–16.4) | 11.1 (4.2–14.3) | 10.5 (5.7–16.6) |
| GHD, % | 13.6% | 43.5% | 44.8% |
| SGA, % | 45.5% | 26.1% | 27.6% |
| Bone dysplasia, % | 31.8% | 17.4% | 24.1% |
| ISS, % | 9.1% | 13.0% | 3.5% |
Abbreviations: GHD, GH deficiency; ISS, idiopathic short stature.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
